Based on the 2003 NCI review, and in consultation with CUMC and NYPH leadership,- and the newly constituted External Scientific.Advisory Board, the HICCC Director outlined a Strategic Plan to restructure and expand the Center.. The Plan included reshaping HICCC Leadership via internal promotions and recruitments and building active internal and external advisory bodies for the HICCC. This plan was successfully implemented with the recruitment of the Deputy Director for Clinical Research (Dr. E. Gelmann), the Associate Director for Biomedical Informatics (Dr. A. Califano), and the internal promotions of the Associate Director for Basic Research (Dr. R. Baer), the Associate Director for Shared Resources (Dr. Benjamin Tycko), and the Associate Director for Population Science (Dr. A. Neugut). In addition, three of the present seven HICCC Programs are led by newly nominated faculty. This reorganization of leadership has been accompanied by an overhaul of Planning and Evaluation and by the redesign of the HICCC's internal and external advisory bodies. The HICCC Director has the responsibility and authority to set priorities and to develop new Programs; nominate and retain scientific leaders and members;select programs, projects and members to receive pilot funding;allocate HICCC resources;'and organize the HICCC as a whole to promote productivity and scientific interactions. The Deputy Director for Clinical Research assists the HICCC Director in accomplishing these goals and in organizing the HICCC's clinical activities. The Director's decisions are based on input from the internal and external advisory bodies. The main internal advisory bodies include: i) the Senior Leadership Team;ii) the Internal Advisory Committee;iii) the Space Committee;iv) the Membership Committee;. and v) the Shared Resource Committee. The External Scientific Advisory Board (ESAB) has been reorganized in its leadership and composition, currently including 11 members representative of the major areas of HICCC research and administration. Funding in the amount of $16,500 is requested for the annual meeting of the ESAB.
| Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419 |
| DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188 |
| Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66 |
| Lee, Andreia; CingÖz, Oya; Sabo, Yosef et al. (2018) Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 516:165-175 |
| Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451 |
| Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6 |
| Kraakman, Michael J; Liu, Qiongming; Postigo-Fernandez, Jorge et al. (2018) PPAR? deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects. J Clin Invest 128:2600-2612 |
| Lee, Younghyun; Pujol Canadell, Monica; Shuryak, Igor et al. (2018) Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep 8:13557 |
| Evans, Lucy P; Newell, Elizabeth A; Mahajan, MaryAnn et al. (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240-251 |
| Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia et al. (2018) Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy. Ophthalmic Genet 39:512-516 |
Showing the most recent 10 out of 331 publications
